Search Results 1301-1310 of 17057 for glomerulonephritis.

  1. Adrenal cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that begins in the adrenal glands. Find out about symptoms, diagnosis and treatment.

  2. Collection of Tissue, Blood Samples, and/or Cystic Fluid in Patients with Benign, Premalignant and/or Malignant Gastrointestinal (GI) Disease - Mayo Clinic

    The goal of this study is to establish and maintain a gastrointestinal disease biospecimen bank containing samples of neoplasms, normal tissue, blood and/or any ...

  3. Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068) - Mayo Clinic

    Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 ...

  4. Waldenstrom macroglobulinemia - Doctors and departments - Mayo Clinic

    Learn about this rare type of white blood cell cancer. Treatments include chemotherapy, targeted therapy, immunotherapy and bone marrow transplant.

  5. Intestinal gas When to see a doctor - Mayo Clinic

    Intestinal gas is a buildup of air in the digestive tract. It is usually not noticed until you burp or pass it rectally, called flatulence.

  6. Medical Research & Education - Mayo Clinic News Network

    ROCHESTER, Minn. — A new study from Mayo Clinic underscores the widespread impact of menopause symptoms on midlife women — and raises concern that most[...] ...

  7. Open-Label extension study of Saroglitazar Magnesium in Participants with Primary Biliary Cholangitis - Mayo Clinic

    The purpose of this study is to evaluate the safety and efficacy of Saroglitazar Magnesium in participants with Primary Biliary Cholangitis. Participation ...

  8. Neurology - Clinical trials

    This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...

  9. Deb Balzer | Mayo Clinic News Network - Page 47 of 73

    It's estimated that about 1 in every 10 Americans has kidney disease. Rising rates of diabetes, high blood pressure and obesity — all risk factors[...] By Deb ...

  10. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors - Mayo Clinic

    Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 ...